Product NDC: | 65224-550 |
Proprietary Name: | Aldex D |
Non Proprietary Name: | PHENYLEPHRINE HYDROCHLORIDE and PYRILAMINE MALEATE |
Active Ingredient(s): | 5; 16 mg/5mL; mg/5mL & nbsp; PHENYLEPHRINE HYDROCHLORIDE and PYRILAMINE MALEATE |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65224-550 |
Labeler Name: | Pernix Therapeutics, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100601 |
Package NDC: | 65224-550-16 |
Package Description: | 473 mL in 1 BOTTLE (65224-550-16) |
NDC Code | 65224-550-16 |
Proprietary Name | Aldex D |
Package Description | 473 mL in 1 BOTTLE (65224-550-16) |
Product NDC | 65224-550 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | PHENYLEPHRINE HYDROCHLORIDE and PYRILAMINE MALEATE |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20100601 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Pernix Therapeutics, LLC |
Substance Name | PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE |
Strength Number | 5; 16 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes |